Related references
Note: Only part of the references are listed.Accuracy of Risk Scores for Patients With Chronic Hepatitis B Receiving Entecavir Treatment
Grace Lai-Hung Wong et al.
GASTROENTEROLOGY (2013)
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
Roeland Zoutendijk et al.
GUT (2013)
Myristoylated PreS1-Domain of the Hepatitis B Virus L-protein Mediates Specific Binding to Differentiated Hepatocytes
Anja Meier et al.
HEPATOLOGY (2013)
Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Optimized HBsAg titer monitoring improves interferon therapy in patients with chronic hepatitis delta
Denis Ouzan et al.
JOURNAL OF HEPATOLOGY (2013)
Prevalence and clinical course of hepatitis delta infection in Greece: A 13-year prospective study
Emanuel K. Manesis et al.
JOURNAL OF HEPATOLOGY (2013)
Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis
Takashi Kumada et al.
JOURNAL OF HEPATOLOGY (2013)
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
Tassilo Volz et al.
JOURNAL OF HEPATOLOGY (2013)
Treatment Options for Hepatitis Delta Virus Infection
Benjamin Heidrich et al.
CURRENT INFECTIOUS DISEASE REPORTS (2013)
Natural history of acute and chronic hepatitis C
Benjamin Maasoumy et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation
Ingmar Mederacke et al.
JOURNAL OF HEPATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome
Benjamin Heidrich et al.
LIVER INTERNATIONAL (2012)
Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum
Karsten Wursthorn et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
JOURNAL OF HEPATOLOGY (2011)
Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study
M. Buti et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Replicative and Transcriptional Activities of Hepatitis B Virus in Patients Coinfected with Hepatitis B and Hepatitis Delta Viruses
Teresa Pollicino et al.
JOURNAL OF VIROLOGY (2011)
Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment
Jan Grabowski et al.
LIVER INTERNATIONAL (2011)
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
Heiner Wedemeyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Outcome of Sustained Virological Responders With Histologically Advanced Chronic Hepatitis C
Timothy R. Morgan et al.
HEPATOLOGY (2010)
Establishment of a Novel Quantitative Hepatitis D Virus (HDV) RNA Assay Using the Cobas TaqMan Platform To Study HDV RNA Kinetics
Ingmar Mederacke et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine
Wael Mansour et al.
JOURNAL OF CLINICAL VIROLOGY (2010)
TELBIVUDINE (LDT) PLUS PEG-INTERFERON (PEGIFN) IN HBEAG-POSITIVE CHRONIC HEPATITIS B - VERY POTENT ANTIVIRAL EFFICACY BUT RISK OF PERIPHERAL NEUROPATHY (PN)
P. Marcellin et al.
JOURNAL OF HEPATOLOGY (2010)
Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D
Melanie Schaper et al.
JOURNAL OF HEPATOLOGY (2010)
Outcome of chronic delta hepatitis in Italy: A long-term cohort study
Grazia Anna Niro et al.
JOURNAL OF HEPATOLOGY (2010)
Natural history and treatment of chronic delta hepatitis
C. Yurdaydin et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis
Kalliopi Zachou et al.
LIVER INTERNATIONAL (2010)
Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead
Heiner Wedemeyer et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma
Raffaella Romeo et al.
GASTROENTEROLOGY (2009)
Virological and clinical characteristics of delta hepatitis in Central Europe
B. Heidrich et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B
Karsten Wursthorn et al.
HEPATOLOGY (2006)
Efficacy of peginterferon alpha-2b in chronic hepatitis delta:: Relevance of quantitative RT-PCR for follow-up
Corinne Castelnau et al.
HEPATOLOGY (2006)
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta
Grazia Anna Niro et al.
HEPATOLOGY (2006)
Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response
Martijn J. ter Borg et al.
HEPATOLOGY (2006)
Treatment of chronic hepatitis delta with pegylated interferon-α2b
Andreas Erhardt et al.
LIVER INTERNATIONAL (2006)
Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B:: A randomized study
CJ Liu et al.
HEPATOLOGY (2006)
Long-term benefit of interferon a therapy of chronic hepatitis D: Regression of advanced hepatic fibrosis
P Farci et al.
GASTROENTEROLOGY (2004)
Share Paper
